Effect of Cash Benefits on Health Care Utilization
- Conditions
- Health Care Utilization
- Interventions
- Other: Cash BenefitOther: No Cash Benefit
- Registration Number
- NCT05622903
- Lead Sponsor
- Harvard Medical School (HMS and HSDM)
- Brief Summary
Using data from the Chelsea Eats program, we propose to study a randomized controlled trial in which the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months during the first two years of the COVID-19 pandemic. We will analyze the impact of the cash benefit on health care utilization and health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3615
- Resident of Chelsea, Massachusetts
- Household income at or below 30% of the U.S. Department of Housing and Urban Development's Area Median Income
- See inclusion criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Group Cash Benefit Participants in the treatment group received up to $400 per month. Control Group No Cash Benefit Participants in the control group did not receive monthly cash benefits.
- Primary Outcome Measures
Name Time Method Emergency department use 10 months Count of visits to the emergency department (ED) using the electronic health record
- Secondary Outcome Measures
Name Time Method Blood pressure 10 months Continuous measure of blood pressure, using the latest available reading or result during trial period
Behavioral health-related ED visit 10 months Visits to the ED with a behavioral health-related diagnosis code
ED visit resulting in admission to the hospital 10 months Visits to the ED that result in a hospitalization
Potentially avoidable ED visit 10 months Visits to the ED that are potentially avoidable, categorized as avoidable according to the previously validated New York University algorithm
Outpatient service use 10 months Office visits and visits for other types of outpatient care such as imaging and procedures
Cholesterol 10 months Continuous measure of cholesterol, using the latest available reading or result during trial period
COVID vaccination 10 months Binary variable for having received at least one dose of any COVID vaccine by the end of the trial period
Hemoglobin A1c 10 months Continuous measure of diabetes, using the latest available reading or result during trial period
Weight 10 months Continuous measure of weight, using the latest available reading or result during trial period
Substance use disorder-related ED visit 10 months Visits to the ED with a substance use disorder-related diagnosis code
Trial Locations
- Locations (1)
Harvard Medical School
🇺🇸Boston, Massachusetts, United States